The electrophysiology lab is changing rapidly due to rapid innovations happening in every component of the lab. In this session, panelists will explore how these innovations are designed to meet current unmet needs and will advance care in the future.

David Fischel, Chairman and CEO, Stereotaxis
Daniel Guerrero, Director of US Clinical Affairs, Volta Medical
Mads Matthiesen, Chief Executive Officer and Co-Founder, CathVision
Kyle Newman, Global Program Manager over the Affera Mapping and Ablation System, Medtronic
Shlomo Shpun, Chief Scientific Officer, TechWald Holding, S.p.A
Berk Tas, Chief Executive Officer and President, SentiAR
Liat Tsofef, Senior Director of Digital, AI, and Customer Collaboration, Biosense Webster

Moderator:
Paul Zei, Cardiac Electrophysiologist, Brigham and Women's Hospital